Du Gangjun, male, was born in 197 1, Taikang, Henan. Dr. Shenyang Pharmaceutical University, postdoctoral fellow of Institute of Biophysics, Chinese Academy of Sciences, professor of Henan University, leader of oncology pharmacology in School of Pharmacy, Henan University, and tutor of master students. Mainly engaged in the teaching and research of traditional Chinese medicine pharmacology and tumor pharmacology. Responsible for Henan Province, National Natural Science Foundation, National 863 Plan, National 973 Plan and other scientific research projects. In 2007, Professor Du Gangjun won the honorary title of "Academic and Technical Leader" in Henan Province.

outline

Du Gangjun's main research: the study on the pharmacology of traditional Chinese medicine and the synergistic and attenuated effects of traditional Chinese medicine prescriptions on chemotherapy drugs in modern anti-tumor research, the study on changing the dosage form of tumor drugs by nanotechnology to enhance the targeting of chemotherapy drugs to tumor tissues, and cell screening to find new anti-tumor traditional Chinese medicine and chemotherapy drugs. And has achieved remarkable results. Du Gangjun and Wei Liang from Institute of Biophysics, Chinese Academy of Sciences published the research results of "Phospholipid-Adriamycin Self-assembled Nanomicelles Promoting Tumor Permeability" in the American National Cancer Institute, which proved for the first time that PEG-derived phospholipid nanomicelles loaded with adriamycin can selectively accumulate in tumor tissues and penetrate into deep tumor tissues, thus increasing the drug concentration in tumor cells, thus significantly enhancing the cytotoxicity of adriamycin, inhibiting tumor growth and prolonging the life of mice. This technology has applied for an international patent.